StreetInsider.com News Articles

Form 8-K Aldeyra Therapeutics, For: Jul 14

Wed, 15 Jul 2026 16:46:00 -0400

si-local-file:///var/storage/secattach/20260715/26774736.html

Form 8-K Aldeyra Therapeutics, For: Jul 14

Wed, 15 Jul 2026 16:46:00 -0400

si-local-file:///var/storage/secattach/20260715/26774736.html

Levicept Appoints Darlene Deptula-Hicks as CFO

Tue, 07 Jul 2026 04:00:00 -0400

Highly Experienced US-Based Public Markets Leader Strengthens Team as Company Drives Late Stage Development of LEVI-04 for Osteoarthritis

SANDWICH, United Kingdom, July 07, 2026 (GLOBE NEWSWIRE) -- Levicept Ltd, a biotechnology company focused on the development of LEVI-04, a first-in-class treatment for osteoarthritis (OA), today announces the appointment of Darlene Deptula-Hicks as Chief Financial Officer (CFO).

Darlene has a wealth of international experience in the biotechnology and pharmaceutical industries, a longstanding track record of raising capital in both private and public equity markets, and of strategic M&A. She is a Board Member and

Levicept Appoints Darlene Deptula-Hicks as CFO

Tue, 07 Jul 2026 04:00:00 -0400

Highly Experienced US-Based Public Markets Leader Strengthens Team as Company Drives Late Stage Development of LEVI-04 for Osteoarthritis

Form 4 Aldeyra Therapeutics, For: Jun 09 Filed by: Miller-Rich Nancy

Thu, 11 Jun 2026 16:27:00 -0400

si-local-file:///var/storage/secattach/20260611/26636086.html

Form 4 Aldeyra Therapeutics, For: Jun 09 Filed by: Miller-Rich Nancy

Thu, 11 Jun 2026 16:27:00 -0400

si-local-file:///var/storage/secattach/20260611/26636086.html

Form 4 Aldeyra Therapeutics, For: Jun 09 Filed by: Phillips Gary M.

Thu, 11 Jun 2026 16:26:00 -0400

si-local-file:///var/storage/secattach/20260611/26636062.html

Form 4 Aldeyra Therapeutics, For: Jun 09 Filed by: Phillips Gary M.

Thu, 11 Jun 2026 16:26:00 -0400

si-local-file:///var/storage/secattach/20260611/26636062.html

Form 4 Aldeyra Therapeutics, For: Jun 09 Filed by: DOUGLAS RICHARD

Thu, 11 Jun 2026 16:26:00 -0400

si-local-file:///var/storage/secattach/20260611/26636074.html

Form 4 Aldeyra Therapeutics, For: Jun 09 Filed by: DOUGLAS RICHARD

Thu, 11 Jun 2026 16:26:00 -0400

si-local-file:///var/storage/secattach/20260611/26636074.html

Form 4 Aldeyra Therapeutics, For: Jun 09 Filed by: Clark William D

Thu, 11 Jun 2026 16:24:00 -0400

si-local-file:///var/storage/secattach/20260611/26636027.html

Form 4 Aldeyra Therapeutics, For: Jun 09 Filed by: Clark William D

Thu, 11 Jun 2026 16:24:00 -0400

si-local-file:///var/storage/secattach/20260611/26636027.html

Form 4 Aldeyra Therapeutics, For: Jun 09 Filed by: Bronstein Ben

Thu, 11 Jun 2026 16:21:00 -0400

si-local-file:///var/storage/secattach/20260611/26635991.html

Form 4 Aldeyra Therapeutics, For: Jun 09 Filed by: Bronstein Ben

Thu, 11 Jun 2026 16:21:00 -0400

si-local-file:///var/storage/secattach/20260611/26635991.html

Form 4 Aldeyra Therapeutics, For: Jun 09 Filed by: Walker Neal

Thu, 11 Jun 2026 16:21:00 -0400

si-local-file:///var/storage/secattach/20260611/26635997.html

Form 4 Aldeyra Therapeutics, For: Jun 09 Filed by: Walker Neal

Thu, 11 Jun 2026 16:21:00 -0400

si-local-file:///var/storage/secattach/20260611/26635997.html

Form 4 Aldeyra Therapeutics, For: Jun 09 Filed by: DEPTULA-HICKS DARLENE M

Thu, 11 Jun 2026 16:18:00 -0400

si-local-file:///var/storage/secattach/20260611/26635933.html

Form 4 Aldeyra Therapeutics, For: Jun 09 Filed by: DEPTULA-HICKS DARLENE M

Thu, 11 Jun 2026 16:18:00 -0400

si-local-file:///var/storage/secattach/20260611/26635933.html

Form 3 Aldeyra Therapeutics, For: Jun 09 Filed by: DEPTULA-HICKS DARLENE M

Thu, 11 Jun 2026 16:13:00 -0400

si-local-file:///var/storage/secattach/20260611/26635781.html

Form 3 Aldeyra Therapeutics, For: Jun 09 Filed by: DEPTULA-HICKS DARLENE M

Thu, 11 Jun 2026 16:13:00 -0400

si-local-file:///var/storage/secattach/20260611/26635781.html

Form 8-K Aldeyra Therapeutics, For: Jun 09

Wed, 10 Jun 2026 06:02:00 -0400

si-local-file:///var/storage/secattach/20260610/26626060.html

Form 8-K Aldeyra Therapeutics, For: Jun 09

Wed, 10 Jun 2026 06:02:00 -0400

si-local-file:///var/storage/secattach/20260610/26626060.html

Aldeyra Therapeutics names Darlene Deptula-Hicks to board of directors

Tue, 09 Jun 2026 20:30:13 -0400

Aldeyra Therapeutics Inc. (NASDAQ: ALDX) announced the appointment of Darlene Deptula-Hicks to its board of directors, according to a company statement.

Deptula-Hicks brings more than 30 years of experience in public and private life science companies across therapeutics, diagnostics, medical devices, and healthcare technologies. She has held senior executive and chief financial officer positions and has experience with initial public offerings, capital raises, strategic partnerships, and merger and acquisition transactions.

She currently serves as acting Chief Financial Officer of Normunity Inc., a clinical-stage biotechnology company focused on cancer therapies. Previously, she was Chief Financial Officer of F-star Therapeutics Inc. Deptula-Hicks holds an

Aldeyra Therapeutics names Darlene Deptula-Hicks to board of directors

Tue, 09 Jun 2026 20:30:13 -0400

Aldeyra Therapeutics Inc. (NASDAQ: ALDX) announced the appointment of Darlene Deptula-Hicks to its board of directors, according to a company statement.

Aldeyra Therapeutics names Darlene Deptula-Hicks to board of directors

Tue, 09 Jun 2026 20:30:13 -0400

Aldeyra Therapeutics Inc. (NASDAQ: ALDX) announced the appointment of Darlene Deptula-Hicks to its board of directors, according to a company statement.